CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-20 | MOORE JOHN R General Counsel | Sale | −50,000 | $28.37 | $1.4M | 3,252 |
| 2024-09-20 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) | −50,000 | 62,558 | ||
| 2024-09-20 | Donovan Joanne M. CMO | Sale | −7,162 | $28.29 | $203K | 14,538 |
| 2024-09-20 | Derakhshan Behrad Chief Business Officer | Option exercise | +42,068 | $1.93 | $81K | 57,189 |
| 2024-09-20 | Derakhshan Behrad Chief Business Officer | Sale | −42,068 | $29.03 | $1.2M | 15,121 |
| 2024-09-20 | Derakhshan Behrad Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −42,068 | 102,949 | ||
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Option exercise | +46,068 | $1.93 | $89K | 81,996 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Sale | −46,068 | $28.59 | $1.3M | 35,928 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Sale | −4,064 | $28.59 | $116K | 31,864 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Sale | −24,960 | $28.59 | $714K | 6,904 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Option exercise | +50,000 | $1.93 | $97K | 56,904 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Sale | −50,000 | $28.55 | $1.4M | 6,904 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −96,068 | 40,990 | ||
| 2024-08-12 | Semigran Marc Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +138,750 | 138,750 | ||
| 2024-08-12 | Semigran Marc Chief Development Officer | Grant or award · Restricted Stock Units | +23,125 | 23,125 | ||
| 2024-08-12 | Russell Alan J Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +138,750 | 138,750 | ||
| 2024-08-12 | Russell Alan J Chief Scientific Officer | Grant or award · Restricted Stock Units | +23,125 | 23,125 | ||
| 2024-08-12 | MOORE JOHN R General Counsel | Grant or award · Stock Option (Right to Buy) | +138,750 | 138,750 | ||
| 2024-08-12 | MOORE JOHN R General Counsel | Grant or award · Restricted Stock Units | +23,125 | 23,125 | ||
| 2024-08-12 | Derakhshan Behrad Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +138,750 | 138,750 |
Page 12 of 26 · 509 trades